trending Market Intelligence /marketintelligence/en/news-insights/trending/9ebyjcyttdzkab1oqyyk7q2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

OncoSec Medical attracts $15M investment from Alpha Holdings

Credit Suisse Research - Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Barclays Research – Now Available In The S&P Global Market Intelligence Aftermarket Research Collection

StreetTalk – Episode 71: Hotel sector faces tough sledding until full COVID-19 solution

Street Talk Episode 71 - Hotel sector faces tough sledding until full COVID-19 solution


OncoSec Medical attracts $15M investment from Alpha Holdings

San Diego-based OncoSec Medical Inc. has attracted a $15 million investment from South Korean semiconductor manufacturer Alpha Holdings Inc.

The drugmaker said the investment will be used to develop its lead DNA-based immunotherapy candidate Tavo, a targeted therapy aimed at treating cancer.

Alpha Holdings will acquire OncoSec stocks at $1.5 per share, and the purchase will be completed in two tranches. The first tranche will close in about 60 days, with the second tranche to close by Dec. 15.

The South Korean company will also get the option to nominate an observer to OncoSec's board after closing the first tranche and then nominate a board member after the second tranche of the investment closes.